Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Small Cell Lung Carcinoma × Enoxaparin × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Venous Thromboembolism 4 Neoplasms 4 Venous Thrombosis 2 Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Malignant Female Reproductive System Neoplasm 1 Abdominal Neoplasms 1

Interventions

Etoposide 30 Carboplatin 28 Cisplatin 20 Topotecan 19 atezolizumab 9 durvalumab 7 PM 01183 6 Irinotecan 5 amrubicin 4 AMG 757 4 rovalpituzumab tesirine 3 PE regimen 3 Dexamethasone 3 tremelimumab 2 pembrolizumab 2 etoposide phosphate 2 apatinib 2 Vitamin E 2 Tiragolumab 2 RRx-001 2 Magnetic Resonance Spectroscopy 2 trilaciclib 1 toripalimab 1 tislelizumab 1 racotumomab 1 olaparib 1 obatoclax 1 marimastat 1 isophosphamide mustard 1 irinotecan sucrosofate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00717938 2017-08-25

RASTEN

Lund University Hospital

Phase 3 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡